Loren Berenbom is a Cardiology physician affiliated with University of Kansas. OpenAlex indexes 80 publications with 469 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4000 Cambridge St Ste G600
Kansas City, KS 661600001
Telephone
913-588-9600Registry record last updated 5 Dec 2018.
Clinical trials
- Prospective Registry of Epicardial LV Leads Placed During Cardiac Surgery Procedures
Sponsor: University of Kansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202519 payments
- Novo Nordisk IncProgram year20257 payments
- Alnylam Pharmaceuticals Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.3%Beta blocker18.3%Metoprolol Succinate54%Carvedilol20%Metoprolol Tartrate13%Sotalol5%Atenolol4%Nadolol2%Nebivolol Hcl2%Part D<11 patientsStatin13.6%Atorvastatin Calcium52%Rosuvastatin Calcium37%Simvastatin9%Pravastatin Sodium2%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15.2%Factor Xa inhibitor13.3%Eliquis68%Xarelto32%Part D≥107 patientsVitamin K antagonist1.2%Warfarin Sodium100%Part D≥13 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.5%SGLT2 inhibitor2.1%Jardiance79%Farxiga21%Part D<11 patientsPotassium supplement0.4%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
2025 - FACTORS ASSOCIATED WITH UNSUCCESSFUL TRANSVENOUS LEAD EXTRACTION: A SINGLE CENTER EXPERIENCE
Journal of the American College of Cardiology
2025 - Safety of catheter ablation in patients with recently implanted cardiac implantable electronic device: A 5‐year experience
Pacing and Clinical Electrophysiology
2024 - Cardiac resynchronization therapy for pacing induced cardiomyopathy: Role of baseline right ventricular pacing burden
Pacing and Clinical Electrophysiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Simari, MD
University of Kansas
Tara Lin, MD
University of Kansas
Diane Cibrik, MD
University of Kansas
Martin Mainster, MD
University of Kansas
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”